NEW YORK, NY - SEPTEMBER 19: In this photo illustration, packages and pills of Zantac, a popular medication which decreases stomach acid production and prevents heartburn, sit on a table on September 19, 2019 in New York City. The FDA recently announced that is has found small amounts of a probable carcinogen in versions of Zantac and other forms of ranitidine. (Photo Illustration by Drew Angerer/Getty Images)

Walgreens and CVS, among other drug stores, have pulled the popular heartburn and acid reflux medication, Zantac, from the shelves due to concerns of a possible link to cancer.

If you are one of the millions of people taking this drug, it’s time to look for an alernative.

The company that makes Zantac announced they have stopped distribution.

The FDA recently discovered that ranitadine, sold as Zantac, contains minimal levels of a substance that may cause cancer.  This is the same chemical found in the blood pressure medication, Lorsatan, which was recently recalled.